ProMED Disease Outbreak Update

Nipah case confirmed in Kerala, India, Ebola in DRC, MERS in Saudi Arabia, Lassa fever in Nigeria.


Information available within this Disease Outbreak Update is produced by Program for Monitoring Emerging Diseases (ProMED).

Note: Content may be edited for style and length.

 

Nipah

Location

Kerala, India
 

Outbreak Update

A 23-year-old college student [in Kochi, Kerala] has been confirmed to be infected with the Nipah virus while 86 others are under medical observation, Kerala Health Minister KK Shailaja said [4 Jun 2019]. See media report here.

As of 5 June 2019, in an official press release from the Ministry of Health and Family Welfare:

The current status is:
Condition of one positive case is stable
A total of 314 contacts are being followed up on daily basis
5 symptomatic contacts have been admitted in quarantine facility at Medical college and samples have been sent for testing.
Video conference conducted with Strategic health Operations Centre (SHOC) has been activated at Central level at NCDC and also 20 calls have been attended to at NCDC control room information to the public.
 

• DNA India report (7 June 2019):

Concerns related to the spread of Nipah in Kerala were allayed further, with Kerala Health Minister KK Shailaja on Friday [7 Jun 2019] saying samples of one more person suspected to be infected with the potentially deadly virus have tested negative.
 

See the full ProMED post here.

MERS-CoV

Location

Saudi Arabia
 

Outbreak Update

Saudi MOH — 29 May 2019 — 9 June 2019

In the period since the last update (MERS-CoV (51): Saudi Arabia (RI,NJ,QS) 20190528.6491342) there have been 2 newly confirmed cases of MERS-CoV infection in Saudi Arabia and 5 outcomes of previously confirmed cases (4 recoveries and 1 death).

Information on newly confirmed cases (2):

[1]
Date of confirmation report: 9 Jun 2019
Case No: 19-1927
MERS from Qusaiba city: 55-year-old male from Qusaiba city, Qassim region
Contact with camels: Unknown
Case classification: Secondary
Current status: Active

[2]
Date of confirmation report: 9 Jun 2019
Case No: 19-1928
MERS from Qaisoumah city: 65-year-old male from Qaisoumah city, Eastern region
Contact with camels: Yes
Case classification: Primary
Current status: Active

Information on newly reported outcomes (5)
Fatality (1)

Case No: 18-1925; Date of confirmation report: 28 May 2019. A 64-year-old male from Riyadh city, Riyadh region. Classified as a primary case with history of contact with camels. Date of outcome report: 6 Jun 2019. Outcome: fatality.

Recoveries (4):

[1] Case No: 18-1914. Date of confirmation report: 7 May 2019. A 31-year-old male from Riyadh city, Riyadh region. Classified as a primary case with unknown history of high-risk exposures. Date of outcome report: 3 Jun 2019. Outcome: recovered

[2] Case No: 18-1915: Date of confirmation report: 11 May 2019. A 70-year-old female from Riyadh city, Riyadh region. Classified as a primary case with unknown history of high-risk exposures. Date of outcome report: 3 Jun 2019. Outcome: recovered

[3] Case No: 18-1918: Date of confirmation report 19 May 2019. A 22-year-old female from Alkharj city, Riyadh region. Classified as a primary case with unknown history of high-risk exposures. Date of outcome report: 6 Jun 2019. Outcome: recovered

[4] Case No: 18-1923: Date of confirmation report: 27 May 2019. A 23-year-old female from Riyadh city, Riyadh region. Classified as a secondary case (type of exposure not specified). Date of outcome report: 6 Jun 2019. Outcome: recovered

The addition of these 2 newly confirmed cases brings the total number of laboratory confirmed infections with MERS-CoV in Saudi Arabia since 1 Jan 2019 to 152 cases including 37 deaths (case fatality ratio 24.3 percent).
 

See the full ProMED post here.

Ebola

Location

Democratic Republic of Congo (North Kivu and Ituri provinces)
 

Outbreak Update

Sat 8 Jun 2019. Epidemiological situation report, DRC Ministry of Health

The epidemiological situation of the Ebola Virus Disease dated 7 Jun 2019:
Since the beginning of the epidemic, the cumulative number of cases is 2047, of which 1953 are confirmed and 94 are probable. In total, there were 1381 deaths (1287 confirmed and 94 probable) and 556 people healed.
273 suspected cases under investigation;
8 new confirmed cases, including 3 in Mandima, 2 in Katwa, 1 in Rwampara, 1 in Butembo and 1 in Mabalako;
8 new confirmed case deaths:
4 community deaths, including 1 in Mandima, 1 in Rwampara, 1 in Butembo and 1 in Mabalako;
4 deaths at CTE, including 2 in Mabalako, 1 in Beni and 1 in Katwa;
4 new healings from ETCs, including 3 in Butembo and 1 in Beni.

Distribution of Ebola Virus Disease (EVD) cases by health zone in the provinces of Ituri and North Kivu as of 7 Jun 2019.
1 new health zone did not report a case for 21 days: Lubero.
1 health zone has started to report cases again: Rwampara
In total, 11 of the 22 affected health zones did not report new confirmed cases for at least 21 days.
 

Outbreak Response

131 267 People vaccinated
263 people vaccinated on 7 Jun 2019.
Of those vaccinated, 36 271 are high-risk contacts (CHRs), 64 931 are contacts of contacts (CC), and 30 065 are front-line providers (PPLs).
People vaccinated by health zone:
33 710 in Katwa, 25 719 in Beni, 17 818 in Butembo, 11 367 in Mabalako, 6390 in Mandima, 4584 in Kalunguta, 3279 in Goma, 3048 in Komanda, 2770 in Musienene, 2569 in Oicha, 2331 in Masereka, 2045 in Vuhovi, 1998 in Lubero, 1980 to Kayna, 1858 to Kyondo, 1487 to Bunia, 1040 to Biena, 1012 to Mutwanga, 690 to Rutshuru, 557 to Rwampara (Ituri), 527 to Nyankunde, 496 to Mangurujipa, 494 to Alimbongo, 420 to Mambasa, 355 in Tchomia, 342 in Kirotshe, 333 in Lolwa, 250 in Mweso, 245 in Kibirizi, 161 in Nyiragongo, 97 in Watsa, and 13 in Kisangani.
The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.

64 357 144 People under control
80 entry points (PoE) and operational health checkpoints (PoC).

111 Contaminated health workers
The cumulative number of confirmed/probable cases among health workers is 111 (5.4% of all confirmed/probable cases), including 37 deaths.

Also see WHO Disease Outbreak News, 6 June 2019
 

See the full ProMED post here

Lassa fever

Location

Nigeria
 

Outbreak Update

Nigeria Centre for Disease Control (NCDC) situation report, Sun 26 May 2019

In the reporting week 21 (20-26 May 2019), 3 new confirmed cases were reported from 2 states with no new deaths recorded.
From 1 Jan 2019 to 19 May 2019, a total of 2582 suspected cases have been reported from 21 states. Of these, 578 were confirmed positive, 15 probable and 1989 negative (not a case).
- Since the onset of the 2019 outbreak, there have been 129 deaths in confirmed cases. Case fatality ratio in confirmed cases is 22.3%.
21 states (Edo, Ondo, Bauchi, Nasarawa, Ebonyi, Plateau, Taraba, FCT, Adamawa, Gombe, Kaduna, Kwara, Benue, Rivers, Kogi, Enugu, Imo, Delta, Oyo, Kebbi and Cross River) have recorded at least one confirmed case across 82 Local Government Areas.
93% of all confirmed cases are from Edo (36%), Ondo (29%), Ebonyi (8%), Bauchi (7%), Taraba (7%) and Plateau (6%)
Predominant age-group affected is 21-40 years (range, older than 1 month to 89 years; median age, 32 years)
The male-to-female ratio for confirmed cases is 1.2:1
In the reporting week 21, no new healthcare worker was affected. A total of 18 healthcare workers have been infected since the onset of the outbreak.
6 patients are currently being treated at various treatment centres across the country.
 

Outbreak Response

Nigeria Centre for Disease Control (NCDC) situation report, Sun 26 May 2019

A total of 7491 contacts have been identified from 20 states. Of these, 572 (7.6%) are currently being followed up, 6847 (91.4%) have completed 21 days of follow-up, while 8 (0.1%) were lost to follow-up. Also, 124 (1.7%) symptomatic contacts have been identified, of which 64 (0.8%) have tested positive.

Outbreak emergency phase declared over based on composite indicators.
National Lassa fever multipartner, multisectoral Technical Working Group (TWG) continues to coordinate the response activities at all levels.
 

See the full ProMED post here

Information available within this Disease Outbreak Update is produced by Program for Monitoring Emerging Diseases (ProMED).

Note: Content may be edited for style and length.